Veko Care renews Australian GMP approval; targets 100 countries by 2025

Veko Care manufactures products for different animals, including Companion Animals (Cats & Dogs), Livestock & Cattle, Equine, Poultry, and speciality products for Aquaculture. The brand’s greatest strength lies in manufacturing niche dosage forms. Veko Care’s unwavering commitment to quality, innovation, and technology has set a new benchmark in the animal healthcare industry. Veko Care has a mission to be the most trusted name in the animal health sector.

Commenting on the achievement, the Chairman of Veko Care, Mr.Manoj Agrawal, said, “We are happy to announce that we have successfully renewed Australian GMP. It is a testament to our commitment to quality and innovation in the animal health space. Our vision is to expand our horizons to 100 countries within the next two years.”

Since its inception, Veko Care has been expertly producing specialized Veterinary Pharmaceuticals in a myriad of dosage forms. The company started its operations in India in 2019 with a niche range of products for companion animals and equine. With a current national sales team of over 50 and an all-India presence, the brand plans to double its team size by the next financial year.  Veko Care has achieved a revenue CAGR of 128% in the last three years and has set a target of $5.5 million for the forthcoming financial year.

For more information, please visit: https://vekocare.com/

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.